235 related articles for article (PubMed ID: 36433737)
1. Reduction of therapeutic antibody self-association using yeast-display selections and machine learning.
Makowski EK; Chen H; Lambert M; Bennett EM; Eschmann NS; Zhang Y; Zupancic JM; Desai AA; Smith MD; Lou W; Fernando A; Tully T; Gallo CJ; Lin L; Tessier PM
MAbs; 2022; 14(1):2146629. PubMed ID: 36433737
[TBL] [Abstract][Full Text] [Related]
2. Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries.
Azevedo Reis Teixeira A; Erasmus MF; D'Angelo S; Naranjo L; Ferrara F; Leal-Lopes C; Durrant O; Galmiche C; Morelli A; Scott-Tucker A; Bradbury ARM
MAbs; 2021; 13(1):1980942. PubMed ID: 34850665
[TBL] [Abstract][Full Text] [Related]
3. Antibodies with Weakly Basic Isoelectric Points Minimize Trade-offs between Formulation and Physiological Colloidal Properties.
Gupta P; Makowski EK; Kumar S; Zhang Y; Scheer JM; Tessier PM
Mol Pharm; 2022 Mar; 19(3):775-787. PubMed ID: 35108018
[TBL] [Abstract][Full Text] [Related]
4. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
[TBL] [Abstract][Full Text] [Related]
5. Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions.
Lai PK; Ghag G; Yu Y; Juan V; Fayadat-Dilman L; Trout BL
MAbs; 2021; 13(1):1991256. PubMed ID: 34747330
[TBL] [Abstract][Full Text] [Related]
6. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.
Tiller KE; Li L; Kumar S; Julian MC; Garde S; Tessier PM
J Biol Chem; 2017 Oct; 292(40):16638-16652. PubMed ID: 28778924
[TBL] [Abstract][Full Text] [Related]
7. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability.
Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM
Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550
[TBL] [Abstract][Full Text] [Related]
8. Facile Preparation of Stable Antibody-Gold Conjugates and Application to Affinity-Capture Self-Interaction Nanoparticle Spectroscopy.
Geng SB; Wu J; Alam ME; Schultz JS; Dickinson CD; Seminer CR; Tessier PM
Bioconjug Chem; 2016 Oct; 27(10):2287-2300. PubMed ID: 27494306
[TBL] [Abstract][Full Text] [Related]
9. Net charge of antibody complementarity-determining regions is a key predictor of specificity.
Rabia LA; Zhang Y; Ludwig SD; Julian MC; Tessier PM
Protein Eng Des Sel; 2018 Nov; 31(11):409-418. PubMed ID: 30770934
[TBL] [Abstract][Full Text] [Related]
10. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
11. Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics.
Ching KH; Berg K; Reynolds K; Pedersen D; Macias A; Abdiche YN; Harriman WD; Leighton PA
MAbs; 2021; 13(1):1862451. PubMed ID: 33491549
[TBL] [Abstract][Full Text] [Related]
12. Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies.
Julian MC; Lee CC; Tiller KE; Rabia LA; Day EK; Schick AJ; Tessier PM
Protein Eng Des Sel; 2015 Oct; 28(10):339-50. PubMed ID: 26386257
[TBL] [Abstract][Full Text] [Related]
13. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
[TBL] [Abstract][Full Text] [Related]
14. Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space.
Makowski EK; Kinnunen PC; Huang J; Wu L; Smith MD; Wang T; Desai AA; Streu CN; Zhang Y; Zupancic JM; Schardt JS; Linderman JJ; Tessier PM
Nat Commun; 2022 Jul; 13(1):3788. PubMed ID: 35778381
[TBL] [Abstract][Full Text] [Related]
15. Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning.
Makowski EK; Wang T; Zupancic JM; Huang J; Wu L; Schardt JS; De Groot AS; Elkins SL; Martin WD; Tessier PM
Nat Biomed Eng; 2024 Jan; 8(1):45-56. PubMed ID: 37666923
[TBL] [Abstract][Full Text] [Related]
16. Beyond affinity: selection of antibody variants with optimal biophysical properties and reduced immunogenicity from mammalian display libraries.
Dyson MR; Masters E; Pazeraitis D; Perera RL; Syrjanen JL; Surade S; Thorsteinson N; Parthiban K; Jones PC; Sattar M; Wozniak-Knopp G; Rueker F; Leah R; McCafferty J
MAbs; 2020; 12(1):1829335. PubMed ID: 33103593
[TBL] [Abstract][Full Text] [Related]
17. Malachite green mediates homodimerization of antibody VL domains to form a fluorescent ternary complex with singular symmetric interfaces.
Szent-Gyorgyi C; Stanfield RL; Andreko S; Dempsey A; Ahmed M; Capek S; Waggoner AS; Wilson IA; Bruchez MP
J Mol Biol; 2013 Nov; 425(22):4595-613. PubMed ID: 23978698
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.
Liu Y; Caffry I; Wu J; Geng SB; Jain T; Sun T; Reid F; Cao Y; Estep P; Yu Y; Vásquez M; Tessier PM; Xu Y
MAbs; 2014; 6(2):483-92. PubMed ID: 24492294
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
[TBL] [Abstract][Full Text] [Related]
20. Facile Affinity Maturation of Antibody Variable Domains Using Natural Diversity Mutagenesis.
Tiller KE; Chowdhury R; Li T; Ludwig SD; Sen S; Maranas CD; Tessier PM
Front Immunol; 2017; 8():986. PubMed ID: 28928732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
